CN1557454A - Medicinal composition for treating psoriasis and preparation method thereof - Google Patents

Medicinal composition for treating psoriasis and preparation method thereof Download PDF

Info

Publication number
CN1557454A
CN1557454A CNA2004100391073A CN200410039107A CN1557454A CN 1557454 A CN1557454 A CN 1557454A CN A2004100391073 A CNA2004100391073 A CN A2004100391073A CN 200410039107 A CN200410039107 A CN 200410039107A CN 1557454 A CN1557454 A CN 1557454A
Authority
CN
China
Prior art keywords
weight portion
radix
weight
powder
zaocys
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CNA2004100391073A
Other languages
Chinese (zh)
Other versions
CN1289122C (en
Inventor
梁锁增
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CNB2004100391073A priority Critical patent/CN1289122C/en
Publication of CN1557454A publication Critical patent/CN1557454A/en
Application granted granted Critical
Publication of CN1289122C publication Critical patent/CN1289122C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

The medicine composition for treating psoriasis is prepared with roasted black tail snake, scorpion, buffalo horn, smilax glabra rhizome, rhubarb and other Chinese medicinal materials. The preparation process includes grinding partial Chinese medicinal materials into coarse powder, decocting the other Chinese medicinal materials, precipitating the medicine decoction to obtain the supernatant, concentrating the supernatant into ointment, mixing the coarse powder and the ointment, drying the mixture, grinding the mixture into fine powder and capsulizing. The medicine is clinically safe, and has high curative rate, no toxic side effect and low recurrence rate.

Description

Psoriatic pharmaceutical composition of a kind of treatment and preparation method thereof
Technical field
The present invention relates to a kind of pharmaceutical composition, particularly relate to the psoriatic Chinese medicine composition and method of making the same of a kind of treatment.
Background technology
The psoriasis traditional Chinese medical science claims psoriasis, and old young men and women all can be ill, but is many with the male adults patient.And certain genetic predisposition is arranged, and morbidity has obvious seasonal, and many winters, spring increase the weight of, and alleviate summer or spontaneous recovery.This disease etiology and pathology is comparatively complicated, many and heat in blood, blood be dry have closely related.The phase of carrying out: how because of feelings will internal injury, obstruction of QI, strongly fragrant heat-transformation of a specified duration and send out; Hyperactivity of heart-fire, scorchingly hot lying prostrate in nutrient blood sent out; Intemperance of taking food, the pungent wine of surfeit is wet, the product of fish raw meat stimulating food, wind symptom, and taste are become estranged, functional activity of QI being not smooth, strongly fragrant heat-transformation of a specified duration is accumulate and is amassed that to feel wind heat poison again in skin evil and send out, and it shows as the skin lesion development soon, pruritus, color is red, and patient's red tongue with thin and yellow fur constantly appears in new rash, dry mouth and tougue, susceptible to lose temper due to restlessness, dry stool yellow urine, wiry and frequent pulse or sliding number are waited the dryness-transformation of intenseness of heat impairment of YIN outside one heat in blood, so card is seen white scales, dry stool, yellow urine.Resting stage: disease is outbreak repeatedly for a long time, and cloudy blood is consumed, and is qi-blood disharmony, living wind of dryness-transformation or passages through which vital energy circulates retardance, and QI and blood is lost fortune, and skin loses to moisten foster and arrives, and waits outside one blood-deficiency and wind-dry.Patient table has xerosis cutis now, and the erythra color is light, desquamation, Tianjin anemia void can not on hold then xerostomia dry pharynx, dizziness and blurred vision, complexion is turned white, the few tongue of light red tongue, soft and thready pulse.
Technology contents
The object of the present invention is to provide a kind of pharmaceutical composition that the treatment psoriasis is had remarkable result.
Another object of the present invention is to provide a kind of treatment psoriatic preparation of drug combination method.
The present invention is achieved through the following technical solutions:
Choose crude drug:
Process Zaocys 10-50 weight portion Scorpio 10-50 weight parts water Cornu Bovis seu Bubali 50-100 weight portion
Rhizoma Smilacis Glabrae 30-150 weight portion Radix Et Rhizoma Rhei 6-20 weight portion Flos Sophorae Immaturus 15-60 weight portion
Radix Clerodenri Cyrtophylli 30-60 weight portion Radix Angelicae Sinensis 15-50 weight portion Radix Glycyrrhizae 6-15 weight portion
Caulis Spatholobi 30-60 weight portion
Optimum ratio of the present invention is:
Process Zaocys 30 weight portion Scorpios 30 weight parts water Cornu Boviss seu Bubali 75 weight portions
The Rhizoma Smilacis Glabrae 90 weight portion Radix Et Rhizoma Rhei 13 weight portion Flos Sophorae Immaturus 40 weight portions
Radix Clerodenri Cyrtophylli 45 weight portion Radix Angelicae Sinensis 30 weight portion Radix Glycyrrhizaes 10 weight portions
Caulis Spatholobi 45 weight portions
The present composition adds pharmaceutically acceptable conventional adjuvant and makes clinical acceptable forms, as capsule, tablet, granule, oral liquid, drop pill, pill, powder, injection etc.
Preparation method of the present invention for will process Zaocys, Scorpio, Radix Et Rhizoma Rhei, the Flos Sophorae Immaturus, Radix Angelicae Sinensis, Radix Glycyrrhizae altogether powder become coarse powder standby; Again Rhizoma Smilacis Glabrae, Caulis Spatholobi, Cornu Bubali, Radix Clerodenri Cyrtophylli decocting are extracted 2-4 time, the taking liquid precipitation was collected clear liquor after 2-6 hour, was condensed into cream, add and to process Zaocys, Scorpio, Radix Et Rhizoma Rhei, the Flos Sophorae Immaturus, Radix Angelicae Sinensis, Radix Glycyrrhizae coarse powder and mix thoroughly, dry back powder is that fine powder is made capsule.
Following experimental example is used to further specify the present invention.
Clinical data: the present composition is divided into the phases of carrying out 259 example from general property psoriasis 726 examples of treatment in nineteen ninety-five-2002 end of the year by simplifying typing, resting stages 467 example; Man's 528 examples, women 198 examples, maximum 62 years old age, minimum 17 years old, wherein 20-40 year 589 examples.The course of disease 1 year accounts for more than 22.2%, one year with interior person's 161 examples and accounted for that person's 157 examples account for 21.6% more than 56.2%, six year in 6 years with interior person's 408 examples.
Side's medicine preparation and application: process Zaocys 30g, Scorpio 30g, Cornu Bubali 75g, Radix Et Rhizoma Rhei 13g, Flos Sophorae Immaturus 40g, Caulis Spatholobi 45g, Rhizoma Smilacis Glabrae 90g, Radix Clerodenri Cyrtophylli 45g, Radix Angelicae Sinensis 30g, Radix Glycyrrhizae 10g powder and fine powder altogether, dress No. zero (0.5 gram/grain) capsule.3 of each clothes, every day 3 times, every month is a course of treatment.
Curative effect judging standard:
Cure: the whole body skin lesion not recidivist of all disappearing more than a year.
Produce effects: the whole body skin lesion all disappears, and drug withdrawal had the recidivist in 1 year.
Effectively: the 1-3 skin lesion course of treatment of taking medicine has minimizing in various degree, and 4-5 still can not disappear the course of treatment fully.
Invalid: as to obey 3 skin lesion course of treatment alleviators not.
Therapeutic outcome: see the following form
Figure A20041003910700041
Conclusion: present composition treatment psoriasis 726 examples, treatment rate is 86%, total effective rate 98%, its great advantage is not aviod certain food, not medicine for external use.Take medicine the shortest two courses of treatment the longest five courses of treatment.Through clinical practice safely, have no side effect, cure rate height, relapse rate are low.
Model case: Xu so-and-so, man 34 years old, peasant, general psoriasis (psoriasis) 8 years.Have a medical check-up as seen: back such as map shape, extremity are the patch shape, and skin lesion place basilar part is light red, and scrape off squama and be sieve shape oozing of blood point, be many with anterior hair line between sending out, little itching, stringy and rolling pulse, red tongue with thin fur is white, and stool does sometimes.Diagnosis; Psoriasis (resting stage).Clothes present composition capsule, each 3, every day 3 times, taking medicine after meal.The obvious attenuation of skin lesion squama after the course of treatment, the squama major part disappears after two courses of treatment, and it is light that erythema is changeed, only surplus duplex, back, the meagre squama of anterior hair line fraction after three courses of treatment, the skin full recovery is normal after four courses of treatment.Due to illness the people is very satisfied, requires to consolidate two months again, and following up a case by regular visits in 6 years so far after the drug withdrawal does not have recurrence.
Embodiment 1:
Process Zaocys 30 gram Scorpios 30 gram Cornu Bubalis 75 grams
The Rhizoma Smilacis Glabrae 90 gram Radix Et Rhizoma Rhei 13 gram Flos Sophorae Immaturus 40 grams
Radix Clerodenri Cyrtophylli 45 gram Radix Angelicae Sinensis 30 gram Radix Glycyrrhizaes 10 grams
Caulis Spatholobi 45 grams
To process Zaocys, Scorpio, Radix Et Rhizoma Rhei, the Flos Sophorae Immaturus, Radix Angelicae Sinensis, Radix Glycyrrhizae altogether powder become coarse powder standby; Rhizoma Smilacis Glabrae, Caulis Spatholobi, Cornu Bubali, Radix Clerodenri Cyrtophylli decocting are extracted 3 times, the taking liquid precipitation was collected clear liquor after 4 hours, was condensed into cream again, added to process Zaocys, Scorpio, Radix Et Rhizoma Rhei, the Flos Sophorae Immaturus, Radix Angelicae Sinensis, Radix Glycyrrhizae coarse powder and mix thoroughly, and dry back powder is a fine powder dress zero capsule.Every 0.5 gram, 100 every bottle.Every day 3 times, obey 3 at every turn, be a course of treatment January.
Embodiment 2:
Process Zaocys 10 gram Scorpios 10 gram Cornu Bubalis 50 grams
The Rhizoma Smilacis Glabrae 30 gram Radix Et Rhizoma Rhei 6 gram Flos Sophorae Immaturus 15 grams
Radix Clerodenri Cyrtophylli 30 gram Radix Angelicae Sinensis 15 gram Radix Glycyrrhizaes 6 grams
Caulis Spatholobi 30 grams
Said medicine technology is routinely made tablet.
Embodiment 3:
Process Zaocys 50 gram Scorpios 50 gram Cornu Bubalis 100 grams
The Rhizoma Smilacis Glabrae 150 gram Radix Et Rhizoma Rhei 20 gram Flos Sophorae Immaturus 60 grams
Radix Clerodenri Cyrtophylli 60 gram Radix Angelicae Sinensis 50 gram Radix Glycyrrhizaes 15 grams
Caulis Spatholobi 60 grams
Said medicine technology is routinely made a material agent.

Claims (4)

1, the psoriatic pharmaceutical composition of a kind of treatment is characterized in that said composition mainly made by following crude drug:
Process Zaocys 10-50 weight portion Scorpio 10-50 weight parts water Cornu Bovis seu Bubali 50-100 weight portion
Rhizoma Smilacis Glabrae 30-150 weight portion Radix Et Rhizoma Rhei 6-20 weight portion Flos Sophorae Immaturus 15-60 weight portion
Radix Clerodenri Cyrtophylli 30-60 weight portion Radix Angelicae Sinensis 15-50 weight portion Radix Glycyrrhizae 6-15 weight portion
Caulis Spatholobi 30-60 weight portion.
2, pharmaceutical composition according to claim 1 is characterized in that said composition mainly made by following crude drug:
Process Zaocys 30 weight portion Scorpios 30 weight parts water Cornu Boviss seu Bubali 75 weight portions
The Rhizoma Smilacis Glabrae 90 weight portion Radix Et Rhizoma Rhei 13 weight portion Flos Sophorae Immaturus 40 weight portions
Radix Clerodenri Cyrtophylli 45 weight portion Radix Angelicae Sinensis 30 weight portion Radix Glycyrrhizaes 10 weight portions
Caulis Spatholobi 45 weight portions.
3, pharmaceutical composition according to claim 1 and 2 is characterized in that said composition adds acceptable accessories and makes acceptable forms clinically, as capsule, tablet, granule, oral liquid, drop pill, pill, powder, injection.
4, pharmaceutical composition according to claim 1 and 2 is characterized in that the preparation method of said composition is: will process Zaocys, Scorpio, Radix Et Rhizoma Rhei, the Flos Sophorae Immaturus, Radix Angelicae Sinensis, Radix Glycyrrhizae altogether powder become coarse powder standby; Again Rhizoma Smilacis Glabrae, Caulis Spatholobi, Cornu Bubali, Radix Clerodenri Cyrtophylli decocting are extracted 2-4 time, the taking liquid precipitation was collected clear liquor after 2-6 hour, was condensed into cream, add and to process Zaocys, Scorpio, Radix Et Rhizoma Rhei, the Flos Sophorae Immaturus, Radix Angelicae Sinensis, Radix Glycyrrhizae coarse powder and mix thoroughly, dry back powder is that fine powder is made capsule.
CNB2004100391073A 2004-02-06 2004-02-06 Medicinal composition for treating psoriasis and preparation method thereof Expired - Fee Related CN1289122C (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CNB2004100391073A CN1289122C (en) 2004-02-06 2004-02-06 Medicinal composition for treating psoriasis and preparation method thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CNB2004100391073A CN1289122C (en) 2004-02-06 2004-02-06 Medicinal composition for treating psoriasis and preparation method thereof

Publications (2)

Publication Number Publication Date
CN1557454A true CN1557454A (en) 2004-12-29
CN1289122C CN1289122C (en) 2006-12-13

Family

ID=34352268

Family Applications (1)

Application Number Title Priority Date Filing Date
CNB2004100391073A Expired - Fee Related CN1289122C (en) 2004-02-06 2004-02-06 Medicinal composition for treating psoriasis and preparation method thereof

Country Status (1)

Country Link
CN (1) CN1289122C (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107095989A (en) * 2017-05-31 2017-08-29 王滋东 One kind treats psoriasic Chinese medicine and preparation method thereof

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107095989A (en) * 2017-05-31 2017-08-29 王滋东 One kind treats psoriasic Chinese medicine and preparation method thereof

Also Published As

Publication number Publication date
CN1289122C (en) 2006-12-13

Similar Documents

Publication Publication Date Title
CN100353983C (en) Chinese medicine preparation for reducing sugar
CN109674958B (en) Traditional Chinese medicine composition with effect of reducing uric acid and preparation method and application thereof
CN102078473B (en) Traditional Chinese medicine preparation for treating chronic hepatitis b and preparation method thereof
CN102205107B (en) Chinese medicinal preparation for treating duodenal ulcer and preparation method thereof
CN102293927B (en) Compound Chinese medicinal preparation with antifatigue and antioxidation effects, and preparation method thereof
CN104958607A (en) Traditional Chinese medicine composition for treating burning mouth syndromes of climacteric women and preparation method thereof
CN106362020B (en) A kind of pine pollen composition and preparation method thereof with improvement defecating feces excretion
CN102688438B (en) Chinese medicinal orally disintegrating tablets for treating infantile diarrhea
CN101785811A (en) Traditional Chinese medicine for senile pruritus treatment
CN101045152A (en) Traditional Chinese medicine composition for treating chronic pelvic inflammatory disease concomitant inflammatory swelling
CN104825821A (en) Medicine for treating diabetes and preparation method thereof
CN104940718A (en) Pharmaceutical composition for treatment of chronic cholecystitis and preparation method thereof
CN101708286B (en) Chinese patent medicament for treating sjogren's syndrome and intractable oral ulcer, and preparation method thereof
CN1289122C (en) Medicinal composition for treating psoriasis and preparation method thereof
CN103989762B (en) Chinese medicine composition of internal organs relieving cough and resolving phlegm and preparation method thereof is rushed down in a kind of heat clearing away
CN102755519A (en) Kudzuvine root-kudzuvine flower anti-canker sore particle and preparation method thereof
CN116159098B (en) Composition for preventing and treating degenerative osteoarthritis lesions
CN115252729B (en) Traditional Chinese medicine composition for treating diabetes and application thereof
CN102671143B (en) Parslane herb Chinese medicinal oral liquid for treating dysentery and preparation method for parslane herb Chinese medicinal oral liquid
CN1314160A (en) Oral pill for curing diabetes and its complication
CN110638909B (en) Traditional Chinese medicine composition for improving Jichuan decoction and preparation method and application thereof
CN1279929C (en) Chinese medicine for treating facial paralysis, preparing method and use
CN105267745A (en) Traditional Chinese medicine composition for treating uremia and preparation method
CN100335111C (en) Medicine for rheumatism and its preparation
CN1064536C (en) Full-divergence promoting medicine for curing fourth-phase carcinoma of stomach and its processing method

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
C19 Lapse of patent right due to non-payment of the annual fee
CF01 Termination of patent right due to non-payment of annual fee